These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26734452)

  • 1. Improving viable low cost generic medication prescription rate in primary care pediatric practice.
    Sudhanthar S; Turner J; Thakur K; Sigal Y
    BMJ Qual Improv Rep; 2015; 4(1):. PubMed ID: 26734452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.
    Newman-Casey PA; Woodward MA; Niziol LM; Lee PP; De Lott LB
    Ophthalmology; 2018 Mar; 125(3):332-339. PubMed ID: 28625684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using default options within the electronic health record to increase the prescribing of generic-equivalent medications: a quasi-experimental study.
    Patel MS; Day S; Small DS; Howell JT; Lautenbach GL; Nierman EH; Volpp KG
    Ann Intern Med; 2014 Nov; 161(10 Suppl):S44-52. PubMed ID: 25402402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Prescribing Generic (Non-proprietary) Drugs in the Prevalence of Therapeutic Inertia in Multiple Sclerosis Care.
    Saposnik G; Mamdani M; Terzaghi M; Saladino ML; Silva B; Tobler PN; Caceres F
    Front Neurol; 2018; 9():835. PubMed ID: 30369904
    [No Abstract]   [Full Text] [Related]  

  • 5. Examining patterns in medication documentation of trade and generic names in an academic family practice training centre.
    Summers A; Ruderman C; Leung FH; Slater M
    BMC Med Educ; 2017 Sep; 17(1):175. PubMed ID: 28938883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians.
    Choudhry NK; Denberg TD; Qaseem A;
    Ann Intern Med; 2016 Jan; 164(1):41-9. PubMed ID: 26594818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choice of generic versus brand-name antidepressants in a regulated prescription drug market: evidence from Taiwan.
    Liu YM; Ou HT; Yang YK
    J Ment Health Policy Econ; 2014 Dec; 17(4):163-72. PubMed ID: 25599280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Chronic Pain Patients Be Adequately Treated Using Generic Pain Medications to the Exclusion of Brand-Name Ones?
    Candido KD; Chiweshe J; Anantamongkol U; Knezevic NN
    Am J Ther; 2016; 23(2):e489-97. PubMed ID: 24914505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What's in a name? Use of brand versus generic drug names in United States outpatient practice.
    Steinman MA; Chren MM; Landefeld CS
    J Gen Intern Med; 2007 May; 22(5):645-8. PubMed ID: 17443372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician use of brand versus generic drug names in 1993-1994 and 2003-2004.
    Kwo EC; Kamat P; Steinman MA
    Ann Pharmacother; 2009 Mar; 43(3):459-68. PubMed ID: 19261956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Attending Practice Style on Generic Medication Prescribing by Residents in the Clinic Setting: An Observational Study.
    Ryskina KL; Dine CJ; Kim EJ; Bishop TF; Epstein AJ
    J Gen Intern Med; 2015 Sep; 30(9):1286-93. PubMed ID: 26173522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of Co-Prescribing NSAID and Gastroprotective Medications for Elders in The Netherlands and Its Association with the Electronic Medical Record.
    Opondo D; Visscher S; Eslami S; Verheij RA; Korevaar JC; Abu-Hanna A
    PLoS One; 2015; 10(6):e0129515. PubMed ID: 26110650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generic medications for you, but brand-name medications for me.
    Keenum AJ; Devoe JE; Chisolm DJ; Wallace LS
    Res Social Adm Pharm; 2012; 8(6):574-8. PubMed ID: 22357268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. North American cost analysis of brand name versus generic drugs for the treatment of glaucoma.
    Malvankar-Mehta MS; Feng L; Hutnik CM
    Clinicoecon Outcomes Res; 2019; 11():789-798. PubMed ID: 31908505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents.
    Sacks CA; Lee CC; Kesselheim AS; Avorn J
    JAMA; 2018 Aug; 320(7):650-656. PubMed ID: 30140875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reasons for the Underutilization of Generic Drugs by US Ophthalmologists: A Survey.
    Dietze J; Priluck A; High R; Havens S
    Ophthalmol Ther; 2020 Dec; 9(4):955-970. PubMed ID: 32813159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generic utilization and cost-sharing for prescription drugs.
    Gibson TB; McLaughlin CG; Smith DG
    Adv Health Econ Health Serv Res; 2010; 22():195-219. PubMed ID: 20575234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. News media coverage of medication research: reporting pharmaceutical company funding and use of generic medication names.
    Hochman M; Hochman S; Bor D; McCormick D
    JAMA; 2008 Oct; 300(13):1544-50. PubMed ID: 18827211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing practices of doctors attending to under fives in a children's outpatient clinic in Owerri, Nigeria.
    Nwolisa CE; Erinaugha EU; Ofoleta SI
    J Trop Pediatr; 2006 Jun; 52(3):197-200. PubMed ID: 16339786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.